290660 — Neofect Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapNeutral

Market Cap
KR₩38bn
Enterprise Value
KR₩35bn
Revenue
KR₩21bn

Annual balance sheet for Neofect Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	14,361	5,805	2,199	23,588	27,029
Net Total Accounts Receivable
Net Total Receivables	3,412	4,084	5,121	4,443	9,510
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	23,093	15,349	12,737	33,537	40,829
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	18,134	20,476	21,900	28,754	22,578
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	57,907	52,540	50,371	71,709	72,358
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	26,823	24,666	28,908	28,712	26,805
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	42,666	40,183	43,886	42,777	33,461
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
ESOP Debt Guarantee
Unrealized Gain / Loss
Other Equity
Total Equity	15,241	12,357	6,485	28,931	38,897
Total Liabilities & Shareholders' Equity	57,907	52,540	50,371	71,709	72,358
Total Common Shares Outstanding
Total Preferred Shares Outstanding